Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRIDGE-TNK EXTEND: rhTNK-tPA Before Thrombectomy for Stroke in Extended Time Window
NCT06987305Phase 3Recruiting
- Sponsor
- Xinqiao Hospital
- Start
- Oct 2025
- Primary completion
- Oct 2027
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, sponsored by Xinqiao Hospital. Started Oct 2025; status: recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06987305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06987305.